Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced gastrointestinal mucositis

Experimental Biology and Medicine

Volumn 234, Issue 4, 2009, Pages 430-441

  Stringer, Andrea M ^a,b,f   Gibson, Rachel J ^c   Logan, Richard M ^c,d   Bowen, Joanne M ^a,b   Yeoh, Ann S J ^a,b   Hamilton, Juliette ^a,b   Keefe, Dorothy M K ^a,b,e  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^e CANCER COUNCIL SOUTH AUSTRALIA   (Australia)

^f HANSON INSTITUTE   (Australia)

Author keywords

Chemotherapy; Intestine; Microflora; Mucositis

Indexed keywords

FLUOROURACIL; MUCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLOSTRIDIUM; COLON; CONTROLLED STUDY; ENTEROCOCCUS; ENZYME RELEASE; ESCHERICHIA; ESCHERICHIA COLI; EXOCYTOSIS; FECES ANALYSIS; FEMALE; GOBLET CELL; INTESTINE FLORA; JEJUNUM; KRUSKAL WALLIS TEST; LACTOBACILLUS; MICROBIOLOGY; MICROFLORA; MUCOSA INFLAMMATION; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS; STREPTOCOCCUS;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BACTERIA; COLONY COUNT, MICROBIAL; ELECTROLYTES; FEMALE; FLUOROURACIL; GASTRIC MUCINS; GASTROINTESTINAL TRACT; GOBLET CELLS; MICROBIAL SENSITIVITY TESTS; MUCOSITIS; RATS; RATS, INBRED STRAINS;

BACTERIA (MICROORGANISMS); BACTEROIDES SP.; CLOSTRIDIUM; ENTEROCOCCUS; ESCHERICHIA; ESCHERICHIA COLI; LACTOBACILLUS; RATTUS; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 66449134522     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0810-RM-301     Document Type: Article

References (46)

1. Keefe DM, Brealey J, Goland GJ, Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47(5):632-637, 2000.
2. Keefe DM, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE. Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci (Lond) 92(4):385-389, 1997. (Pubitemid 27163097)
3. Pico JL, Avila-Garavito A, Naccache P. Mucositis: its occurrence, consequences, and treatment in the oncology setting. Oncologist 3(6):446-451, 1998. (Pubitemid 29009309)
4. Fata F, Ron IG, Kemeny N, O'Reilly E, Klimstra D, Kelsen DP. 5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma. Cancer 86(7):1129-1134, 1999. (Pubitemid 29446993)
5. Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Burns J, Keefe DM. Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat. Exp Biol Med (Maywood) 232(1):96-106, 2007. (Pubitemid 46091606)
6. Von Bultzingslowen I, Adlerberth I, Wold AE, Dahlen G, Jontell M. Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria. Oral Microbiol Immunol 18(5):278-284, 2003. (Pubitemid 37087258)
7. Simon GL, Gorbach SL. Intestinal microflora. Med Clin North Am 66(3):557-574, 1982.
8. Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenterology 86(1):174-193, 1984. (Pubitemid 14177335)
9. Simon GL, Gorbach SL. The human intestinal microflora. Dig Dis Sci 31(9 Suppl):147S-162S, 1986. (Pubitemid 16017848)
10. Gustafsson BE. The physiological importance of the colonic microflora. Scand J Gastroenterol Suppl 77:117-131, 1982. (Pubitemid 12011606)
11. Umesaki Y, Setoyama H. Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. Microbes Infect 2(11):1343-1351, 2000.
12. Rhee KJ, Sethupathi P, Driks A, Lanning DK, Knight KL. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J Immunol 172(2):1118-1124, 2004. (Pubitemid 38113772)
13. Heller F, Duchmann R. Intestinal flora and mucosal immune responses. Int J Med Microbiol 293(1):77-86, 2003. (Pubitemid 36534599)
14. Robbe C, Capon C, Coddeville B, Michalski JC. Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem J 384(Pt 2):307-316, 2004. (Pubitemid 39656243)
15. Specian RD, Oliver MG. Functional biology of intestinal goblet cells. Am J Physiol 260(2 Pt 1):C183-C193, 1991.
16. Deplancke B, Gaskins HR. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr 73(6):1131S-1141S, 2001. (Pubitemid 32496957)
17. Gusils C, Morata V, Gonzalez S. Determination of bacterial adhesion to intestinal mucus. Methods Mol Biol 268:411-415, 2004.
18. Ikuno N, Soda H, Watanabe M, Oka M. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. J Natl Cancer Inst 87(24):1876-1883, 1995.
19. Verburg M, Renes IB, Meijer HP, Taminiau JA, Buller HA, Einerhand AW, Dekker J. Selective sparing of goblet cells and paneth cells in the intestine of methotrexate-treated rats. Am J Physiol Gastrointest Liver Physiol 279(5):G1037-G1047, 2000.
20. Leiper K, Campbell BJ, Jenkinson MD, Milton J, Yu LG, Democratis J, Rhodes JM. Interaction between bacterial peptides, neutrophils and goblet cells: a possible mechanism for neutrophil recruitment and goblet cell depletion in colitis. Clin Sci (Lond) 101(4):395-402, 2001. (Pubitemid 32929855)
21. Gibson RJ, Bowen JM, Inglis MR, Cummins AG, Keefe DM. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol 18(9):1095-1100, 2003. (Pubitemid 37175953)
22. Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, Yin S, Hill DC, Wiemann B, et al. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 58(5):933-939, 1998. (Pubitemid 28182461)
23. Meslin JC, Fontaine N, Andrieux C. Variation of mucin distribution in the rat intestine, caecum and colon: effect of the bacterial flora. Comp Biochem Physiol A Mol Integr Physiol 123(3):235-239, 1999. (Pubitemid 29395568)
24. Cool JC, Dyer JL, Xian CJ, Butler RN, Geier MS, Howarth GS. Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats. Growth Horm IGF Res 15(1):72-82, 2005. (Pubitemid 40220858)
25. Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM. Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther 7(7):1139-1145, 2008.
26. Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemother Pharmacol 63(2):239-251, 2009.
27. Barcelo A, Claustre J, Moro F, Chayvialle JA, Cuber JC, Plaisancie P. Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut 46(2):218-224, 2000. (Pubitemid 30305848)
28. Layton A, McKay L, Williams D, Garrett V, Gentry R, Sayler G. Development of Bacteroides 16S rRNA gene TaqMan-based real-time PCR assays for estimation of total, human, and bovine fecal pollution in water. Appl Environ Microbiol 72(6):4214-4224, 2006. (Pubitemid 43894889)
29. Penders J, Vink C, Driessen C, London N, Thijs C, Stobberingh EE. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett 243(1):141-147, 2005.
30. Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97(6):1166-1177, 2004. (Pubitemid 39573940)
31. Sakai H, Procop GW, Kobayashi N, Togawa D, Wilson DA, Borden L, Krebs V, Bauer TW. Simultaneous detection of Staphylococcus aureus and coagulase-negative staphylococci in positive blood cultures by real-time PCR with two fluorescence resonance energy transfer probe sets. J Clin Microbiol 42(12):5739-5744, 2004. (Pubitemid 39664361)
32. Bodet CA 3rd, Jorgensen JH, Drutz DJ. Antibacterial activities of antineoplastic agents. Antimicrob Agents Chemother 28(3):437-439, 1985.
33. Milles S, Muggia A, Spiro H. Colonic histologic changes induced by 5-Fluorouracil. Gastroenterology 43(1):391-399, 1962.
34. Saegusa Y, Ichikawa T, Iwai T, Goso Y, Okayasu I, Ikezawa T, Shikama N, Saigenji K, Ishihara K. Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis. Scand J Gastroenterol 43(1):59-63, 2008.
35. Plaisancie P, Bosshard A, Meslin JC, Cuber JC. Colonic mucin discharge by a cholinergic agonist, prostaglandins, and peptide YY in the isolated vascularly perfused rat colon. Digestion 58(2):168-175, 1997. (Pubitemid 27163168)
36. McConalogue K. Furness JB. Gastrointestinal neurotransmitters. Baillieres Clin Endocrinol Metab 8(1):51-76, 1994. (Pubitemid 24042416)
37. Inomata A, Horii I, Suzuki K. 5-Fluorouracil-induced intestinal toxicity: what determines the severity of damage to murine intestinal crypt epithelia? Toxicol Lett 133(2-3):231-240, 2002.
38. Wei ZG, Li GX, Huang XC, Zhen L, Yu J, Deng HJ, Qing SH, Zhang C. Pharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats. World J Gastroenterol 14(14):2179-2186, 2008.
39. Nomoto K, Yokokura T, Mitsuyama M, Yoshikai Y, Nomoto K. Prevention of indigenous infection of mice with Escherichia coli by nonspecific immunostimulation. Antimicrob Agents Chemother 36(2):361-367, 1992.
40. Nomoto K, Yokokura T, Nomoto K. Prevention of 5-fluorouracil-induced infection with indigenous Escherichia coli in tumor-bearing mice by nonspecific immunostimulation. Can J Microbiol 38(8):774-778, 1992.
41. Tancrede CH, Andremont AO. Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J Infect Dis 152(1):99-103, 1985. (Pubitemid 15038840)
42. Wells CL, Ferrieri P, Weisdorf DJ, Rhame FS. The importance of surveillance stool cultures during periods of severe neutropenia. Infect Control 8(8):317-319, 1987.
43. Quigley EM. Probiotics in the management of colonic disorders. Curr Gastroenterol Rep 9(5):434-440, 2007.
44. Bowen JM, Stringer AM, Gibson RJ, Yeoh AS, Hannam S, Keefe DM. VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol Ther 6(9):1449-1454, 2007.
45. Perry M, Ed. The Chemotherapy Source Book (2nd ed.). Baltimore: Williams & Wilkins, pp 1518, 1997.
46. Tortora G, Grabowski S. Principles of Anatomy and Physiology (7th ed.). New York: Harper Collins, pp 999, 1993.